Skip to main content
SpringerLink
Log in

Ghrelin and the metabolic balance

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Several studies have provided evidence that ghrelin is involved in the regulation of metabolic balance. Recent data provide evidence that when studying the effects of ghrelin on energy balance, differential influences of the acylated and non-acylated forms of the peptide must be considered. Although the correlation between the two forms is good, they may be different hormones with opposite actions with nonacylated ghrelin being able to antagonize some of the effects of the acylated form. Future studies will reveal which of the two forms of ghrelin, the acylated or non-acylated forms, dominates and determines the net influence on energy balance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–60.

    Article  CAS  PubMed  Google Scholar 

  2. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908–13.

    Article  CAS  PubMed  Google Scholar 

  3. Asakawa A, Inui A, Fujimiya M, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54: 18–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Ariyasu H, Takaya K, Iwakura H, et al. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 2005, 146: 355–64.

    Article  CAS  PubMed  Google Scholar 

  5. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707–9.

    Article  CAS  PubMed  Google Scholar 

  6. Katsuki A, Urakawa H, Gabazza EC, et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004, 151: 573–7.

    Article  CAS  PubMed  Google Scholar 

  7. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 2005, 62: 1–17.

    Article  CAS  Google Scholar 

  8. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003, 23: 7973–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003, 88: 853–7.

    Article  CAS  PubMed  Google Scholar 

  10. St-Pierre DH, Karelis AD, Cianflone K, et al. Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab 2004, 89: 5993–7.

    Article  CAS  PubMed  Google Scholar 

  11. Marzullo P, Verti B, Savia G, et al. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004, 89: 936–9.

    Article  CAS  PubMed  Google Scholar 

  12. Muccioli G, Pons N, Ghe C, Catapano F, Granata R, Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenolinduced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004, 498: 27–35.

    Article  CAS  PubMed  Google Scholar 

  13. Choi K, Roh SG, Hong YH, et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003, 144: 754–9.

    Article  CAS  PubMed  Google Scholar 

  14. Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skelet al muscle. Am J Physiol Endocrinol Metab 2005, 288: E228–35.

    Article  CAS  PubMed  Google Scholar 

  15. Kim MS, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004, 18: 2291–301.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang W, Zhao L, Lin TR, et al. Inhibition of adipogenesis by ghrelin. Mol Biol Cell 2004, 15: 2484–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Thompson NM, Gill DA, Davies R, et al. Ghrelin and desoctanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004, 145: 234–42.

    Article  CAS  PubMed  Google Scholar 

  18. Ott V, Fasshauer M, Dalski A, et al. Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm Metab Res 2002, 34: 640–5.

    Article  CAS  PubMed  Google Scholar 

  19. Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51: 124–9.

    Article  CAS  PubMed  Google Scholar 

  20. Ukkola O. Ghrelin and insulin metabolism. Eur J Clin Invest 2003, 33: 183–5.

    Article  CAS  PubMed  Google Scholar 

  21. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50: 1714–9.

    Article  CAS  PubMed  Google Scholar 

  22. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87: 240–4.

    Article  CAS  PubMed  Google Scholar 

  23. Erdmann J, Topsch R, Lippl F, Gussmann P, Schusdziarra V. Postprandial response of plasma ghrelin levels to various test meals in relation to food intake, plasma insulin, and glucose. J Clin Endocrinol Metab 2004, 89: 3048–54.

    Article  CAS  PubMed  Google Scholar 

  24. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52: 2546–53.

    Article  PubMed  Google Scholar 

  25. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001, 86: 5083–6.

    Article  CAS  PubMed  Google Scholar 

  26. Broglio F, Benso A, Castiglioni C, et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003, 88: 1537–42.

    Article  CAS  PubMed  Google Scholar 

  27. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab 2003, 88: 701–4.

    Article  CAS  PubMed  Google Scholar 

  28. Murata M, Okimura Y, Iida K, et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002, 277: 5667–74.

    Article  CAS  PubMed  Google Scholar 

  29. Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002, 87: 3997–4000.

    Article  CAS  PubMed  Google Scholar 

  30. Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 2002, 25: RC36–8.

    CAS  PubMed  Google Scholar 

  31. Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001, 281: 1220–5.

    Article  CAS  PubMed  Google Scholar 

  32. Gauna C, Meyler FM, Janssen JA, et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004, 89: 5035–42.

    Article  CAS  PubMed  Google Scholar 

  33. Gauna C, Delhanty PJ, Hofland LJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005, 90: 1055–60.

    Article  CAS  PubMed  Google Scholar 

  34. Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S. Role of ghrelin in streptozotocin-induced diabetic hyperphagia. Endocrinology 2002, 143: 4934–7.

    Article  CAS  PubMed  Google Scholar 

  35. Murdolo G, Lucidi P, Di Loreto C, et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes 2003, 52: 2923–7.

    Article  CAS  PubMed  Google Scholar 

  36. Holdstock C, Ludvigsson J, Karlsson FA. Abnormal ghrelin secretion in new onset childhood Type 1 diabetes. Diabetologia 2004, 47: 150–1.

    Article  CAS  PubMed  Google Scholar 

  37. Soriano-Guillen L, Barrios V, Lechuga-Sancho A, Chowen JA, Argente J. Response of circulating ghrelin levels to insulin therapy in children with newly diagnosed type 1 diabetes mellitus. Pediatr Res 2004, 55: 830–5.

    Article  CAS  PubMed  Google Scholar 

  38. Ostergard T, Hansen TK, Nyholm B, et al. Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes. Diabetologia 2003, 46: 134–6.

    CAS  PubMed  Google Scholar 

  39. Baessler A, Hasinoff MJ, Fischer M, et al. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes 2005, 54: 259–67.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Ukkola O, Ravussin E, Jacobson P, et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 2001, 86: 3996–9.

    Article  CAS  PubMed  Google Scholar 

  41. Ukkola O, Ravussin E, Jacobson P, et al. Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res 2002, 10: 782–91.

    Article  CAS  PubMed  Google Scholar 

  42. Poykko S, Ukkola O, Kauma H, Savolainen MJ, Kesaniemi YA. Ghrelin Arg51 Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 2003, 46: 455–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Biocenter Oulu, University of Oulu, Kajaanintie 50, P.O. Box 5000, Oulu, FIN-90014, Finland

    O. Ukkola MD

Authors
  1. O. Ukkola MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Ukkola MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ukkola, O. Ghrelin and the metabolic balance. J Endocrinol Invest 28, 849–852 (2005). https://doi.org/10.1007/BF03347580

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347580

Key-words

Search

Navigation